Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development
Viruses · 2023
DOI: 10.3390/v15040914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Janet K Yamamoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative, Diagnostic, and Population Medicine (CDPM), College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, …. Hauptthemen laut MEDLINE: Coronavirus, Feline, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: J.K.Y. Miscellaneous Donors Account, SK CVM Startup fund 211.
Abstract (Originalsprache)
The current study was initiated when our specific-pathogen-free laboratory toms developed unexpectedly high levels of cross-reactive antibodies to human SARS-CoV-2 (SCoV2) receptor binding domain (RBD) upon mating with feline coronavirus (FCoV)-positive queens. Multi-sequence alignment analyses of SCoV2 Wuhan RBD and four strains each from FCoV serotypes 1 and 2 (FCoV1 and FCoV2) demonstrated an amino acid sequence identity of 11.5% and a similarity of 31.8% with FCoV1 RBD (12.2% identity and 36.5% similarity for FCoV2 RBD). The sera from toms and queens cross-reacted with SCoV2 RBD and reacted with FCoV1 RBD and FCoV2 spike-2, nucleocapsid, and membrane proteins, but not with FCoV2 RBD. Thus, the queens and toms were infected with FCoV1. Additionally, the plasma from six FCoV2-inoculated cats reacted with FCoV2 and SCoV2 RBDs, but not with FCoV1 RBD. Hence, the sera from both FCoV1-infected cats and FCoV2-infected cats developed cross-reactive antibodies to SCoV2 RBD. Furthermore, eight group-housed laboratory cats had a range of serum cross-reactivity to SCoV2 RBD even 15 months later. Such cross-reactivity was also observed in FCoV1-positive group-housed pet cats. The SCoV2 RBD at a high non-toxic dose and FCoV2 RBD at a 60–400-fold lower dose blocked the in vitro FCoV2 infection, demonstrating their close structural conformations essential as vaccine immunogens. Remarkably, such cross-reactivity was also detected by the peripheral blood mononuclear cells of FCoV1-infected cats. The broad cross-reactivity between human and feline RBDs provides essential insights into developing a pan-CoV vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comparative, Diagnostic, and Population Medicine (CDPM), College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
- Laboratories of Comparative Immunology & Virology for Companion Animals, CDPM, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
- Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
- Laboratory of Veterinary Infectious Disease, Department of Veterinary Medicine, Kitasato University, Tokyo 108-8641, Japan.
- Department of Small Animal Clinical Science, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
ORCID-Profile: Lekshmi K Edison, Tomomi Takano, Chiquitha D Crews, Apichai Tuanyok, Sayaka Shiomitsu, Stephen M Tompkins, John G Morris, Bikash Sahay
Förderung
- J.K.Y. Miscellaneous Donors Account
- SK CVM Startup fund 211
Zitieren
APA
Yamamoto, J. K., Edison, L. K., Rowe-Haas, D. K., Takano, T., Gilor, C., Crews, C. D., Tuanyok, A., Arukha, A. P., Shiomitsu, S., Walden, H. D. S., Hohdatsu, T., Tompkins, S. M., Morris, J. G., Sahay, B., & Kariyawasam, S. (2023). Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. https://doi.org/10.3390/v15040914
Vancouver
Yamamoto JK, Edison LK, Rowe-Haas DK, Takano T, Gilor C, Crews CD, et al. Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. 2023. doi:10.3390/v15040914
BibTeX
@article{Yamamoto2023,
author = {Yamamoto, Janet K and Edison, Lekshmi K and Rowe-Haas, Dawne K and Takano, Tomomi and Gilor, Chen and Crews, Chiquitha D and Tuanyok, Apichai and Arukha, Ananta P and Shiomitsu, Sayaka and Walden, Heather D S and Hohdatsu, Tsutomu and Tompkins, Stephen M and Morris, John G and Sahay, Bikash and Kariyawasam, Subhashinie},
title = {Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040914}
}
EUVIMED